Aaron S Kelly Selected Research

Obesity

2/2024	Current and future state of pharmacological management of pediatric obesity.
1/2024	SMART use of medications for the treatment of adolescent severe obesity: A sequential multiple assignment randomized trial protocol.
10/2023	Changes in adipose tissue distribution and relation to cardiometabolic risk factors after Roux-en-Y gastric bypass in adolescents.
3/2023	Once-Weekly Semaglutide in Adolescents with Obesity. Reply.
1/2023	Semaglutide treatment for obesity in teenagers: a plain language summary of the STEP TEENS research study.
1/2023	Household Income, Cortisol, and Obesity During Early Childhood: A Prospective Longitudinal Study.
1/2023	Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4 mg.
1/2023	Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents.
1/2023	Current and future pharmacotherapies for obesity in children and adolescents.
1/2023	Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: A post hoc analysis of the randomized, placebo-controlled SCALE Teens trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aaron S Kelly Research Topics

Disease

36	Obesity 02/2024 - 01/2006
24	Weight Loss (Weight Reduction) 02/2024 - 07/2006
20	Morbid Obesity 02/2024 - 04/2013
15	Pediatric Obesity 02/2024 - 07/2011
10	Overweight 01/2023 - 12/2004
9	Type 2 Diabetes Mellitus (MODY) 01/2023 - 07/2007
9	Inflammation (Inflammations) 12/2016 - 12/2004
9	Insulin Resistance 07/2015 - 01/2006
6	Body Weight (Weight, Body) 01/2023 - 07/2007
6	Hypertension (High Blood Pressure) 01/2019 - 07/2007
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2006
3	Chronic Disease (Chronic Diseases) 02/2024 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2015 - 12/2010
2	Prediabetic State (Prediabetes) 01/2023 - 01/2016
2	Abdominal Obesity 01/2018 - 06/2012
2	Hyperemia 03/2016 - 06/2012
2	Glucose Intolerance 01/2016 - 06/2012
1	Hyperglycemia 01/2023
1	Cholelithiasis 12/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Atherosclerosis 01/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2018
1	Mucopolysaccharidosis I (Hurler Syndrome) 01/2018
1	Malnutrition (Nutritional Deficiencies) 12/2016
1	Hypercapnia 03/2016
1	Musculoskeletal Pain 01/2016
1	Cardiotoxicity 06/2014
1	Osteosarcoma (Osteogenic Sarcoma) 10/2013
1	Weight Gain 04/2012
1	Nausea 02/2012
1	Acanthosis Nigricans 01/2010
1	Rupture 09/2007
1	Dyslipidemias (Dyslipidemia) 09/2007

Drug/Important Bio-Agent (IBA)

11	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2006
11	Insulin (Novolin)FDA Link 01/2018 - 12/2004
9	LipidsIBA 12/2022 - 01/2006
7	Triglycerides (Triacylglycerol)IBA 06/2022 - 07/2006
6	Topiramate (Topamax)FDA LinkGeneric 01/2024 - 01/2015
6	Glucagon-Like Peptide-1 ReceptorIBA 01/2023 - 06/2012
6	C-Reactive ProteinIBA 10/2013 - 07/2007
5	Exenatide (Byetta)FDA Link 02/2024 - 02/2012
5	semaglutideIBA 03/2023 - 12/2022
5	Liraglutide FDA Link 01/2023 - 01/2020
5	CholesterolIBA 10/2013 - 07/2006
4	Phentermine (Adipex-P)FDA LinkGeneric 01/2024 - 01/2018
4	oxidized low density lipoproteinIBA 06/2012 - 07/2007
4	AdipokinesIBA 04/2012 - 01/2006
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2024 - 07/2013
3	HDL CholesterolIBA 12/2022 - 01/2018
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2013 - 06/2012
3	LeptinIBA 04/2012 - 05/2007
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023 - 01/2018
2	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 07/2007
2	Atorvastatin (Lipitor)FDA Link 01/2019 - 11/2006
2	Xanthine OxidaseIBA 01/2016 - 04/2014
2	HDL LipoproteinsIBA 10/2013 - 08/2012
2	Lipoprotein(a)IBA 10/2013 - 08/2012
2	ApolipoproteinsIBA 10/2013 - 08/2012
2	Fibrinogen (Factor I)FDA Link 10/2013 - 08/2012
2	Hemoglobins (Hemoglobin)IBA 04/2013 - 07/2007
2	AdiponectinIBA 04/2012 - 07/2007
2	LDL CholesterolIBA 03/2012 - 07/2006
2	Carvedilol (Coreg)FDA LinkGeneric 02/2012 - 07/2007
2	Interleukin-6 (Interleukin 6)IBA 07/2011 - 07/2007
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2007 - 07/2007
2	8-epi-prostaglandin F2alphaIBA 07/2007 - 05/2007
1	Hormones (Hormone)IBA 02/2024
1	IncretinsIBA 01/2023
1	vasectrin I (VS I)IBA 01/2023
1	Alanine Transaminase (SGPT)IBA 12/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2022
1	AndrogensIBA 01/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2016
1	Uric Acid (Urate)IBA 01/2016
1	AnthracyclinesIBA 06/2014
1	EnzymesIBA 04/2014
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2013
1	Biomarkers (Surrogate Marker)IBA 08/2012
1	Metformin (Glucophage)FDA LinkGeneric 06/2012
1	Lisinopril (Prinivil)FDA LinkGeneric 02/2012
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 02/2012
1	Rosiglitazone (Avandia)FDA Link 11/2007
1	Glyburide (Glibenclamide)FDA LinkGeneric 11/2007
1	Metoprolol (Toprol-XL)FDA LinkGeneric 07/2007
1	ResistinIBA 07/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007

Therapy/Procedure

26	Therapeutics 02/2024 - 09/2006
13	Bariatric Surgery 02/2024 - 10/2013
13	Drug Therapy (Chemotherapy) 01/2023 - 11/2015
4	Precision Medicine 01/2019 - 01/2017
2	Cell Transplantation 01/2018 - 07/2015
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2023
1	Aftercare (After-Treatment) 01/2019
1	Transplantation 01/2018
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2017
1	Diet Therapy (Therapy, Diet) 04/2008